v3.19.2
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss    
Sales $ 790,379 $ 501,333
Cost of Sales 336,085 253,163
Gross Margin 454,294 248,170
Operating expenses    
Sales and marketing 583,732 542,659
Research and development 816,523 676,743
General and administrative 841,693 979,479
Share-based compensation expense (Note 11) 287,757 595,412
Amortization (Note 4) 69,314 71,053
Depreciation (Note 7) 23,970 17,595
Total operating expenses 2,622,989 2,882,941
Other (income) expenses    
Accretion expense 0 134,251
Fair Value Adjustment 0 44,087
Gain/Loss on mark to market re-evaluation 0 (2,048,697)
Other expense 14,296 37,420
Foreign exchange (62,347) (41,134)
Total other expenses (48,051) (1,874,073)
Net loss and comprehensive loss for the period $ (2,120,644) $ (760,698)
Loss per share - basic and diluted $ (0.55) $ (0.44)
Weighted average number of shares outstanding - basic and diluted 3,858,637 1,716,728

Source